Topography of the sensations in primary restless legs syndrome.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 22704032)

Published in J Neurol Sci on June 15, 2012

Authors

Elias Georges Karroum1, Smaranda Leu-Semenescu, Isabelle Arnulf

Author Affiliations

1: Unité des Pathologies du Sommeil, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.

Articles by these authors

Narcolepsy with cataplexy. Lancet (2007) 4.81

Iron deficiency in children with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med (2004) 2.46

Impact of restless legs syndrome and iron deficiency on attention-deficit/hyperactivity disorder in children. Sleep Med (2007) 2.28

Sleep and sex: what can go wrong? A review of the literature on sleep related disorders and abnormal sexual behaviors and experiences. Sleep (2007) 2.19

Is obstructive sleep apnea a problem in Parkinson's disease? Sleep Med (2009) 2.09

Effects of iron supplementation on attention deficit hyperactivity disorder in children. Pediatr Neurol (2008) 2.08

Dreamlike mentations during sleepwalking and sleep terrors in adults. Sleep (2009) 1.76

Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial. Lancet Neurol (2013) 1.71

Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy. Nat Genet (2010) 1.67

Diaphragm pacing improves sleep in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2011) 1.58

ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet (2013) 1.55

Restoration of normal motor control in Parkinson's disease during REM sleep. Brain (2007) 1.47

Fight or flight? Dream content during sleepwalking/sleep terrors vs. rapid eye movement sleep behavior disorder. Sleep Med (2013) 1.47

Can we still dream when the mind is blank? Sleep and dream mentations in auto-activation deficit. Brain (2013) 1.42

A single-question screen for rapid eye movement sleep behavior disorder: a multicenter validation study. Mov Disord (2012) 1.42

Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France. Brain (2013) 1.39

Family history of idiopathic REM behavior disorder: a multicenter case-control study. Neurology (2013) 1.39

Restless legs syndrome and attention-deficit/hyperactivity disorder: a review of the literature. Sleep (2005) 1.34

A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes. J Clin Endocrinol Metab (2009) 1.32

Idiopathic hypersomnia with and without long sleep time: a controlled series of 75 patients. Sleep (2009) 1.23

An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients. Neurobiol Dis (2007) 1.15

Eating disorder and metabolism in narcoleptic patients. Sleep (2007) 1.11

Scales to assess sleep impairment in Parkinson's disease: critique and recommendations. Mov Disord (2010) 1.10

Attenuation of obstructive sleep apnea by compression stockings in subjects with venous insufficiency. Am J Respir Crit Care Med (2011) 1.09

Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study. Ann Neurol (2015) 1.08

Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study. J Sleep Res (2013) 1.07

Kleine-Levin syndrome in 120 patients: differential diagnosis and long episodes. Ann Neurol (2015) 1.06

Night-to-night variability of muscle tone, movements, and vocalizations in patients with REM sleep behavior disorder. J Clin Sleep Med (2010) 1.03

The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson's disease. Brain (2013) 1.02

Do the eyes scan dream images during rapid eye movement sleep? Evidence from the rapid eye movement sleep behaviour disorder model. Brain (2010) 1.01

Comorbidity and medication in REM sleep behavior disorder: a multicenter case-control study. Neurology (2014) 0.97

Sleep disturbances in patients with parkinsonism. Nat Clin Pract Neurol (2008) 0.97

English translations of the first clinical reports on narcolepsy and cataplexy by Westphal and Gélineau in the late 19th century, with commentary. J Clin Sleep Med (2007) 0.95

Sleep-related eating disorder versus sleepwalking: a controlled study. Sleep Med (2012) 0.94

A motor signature of REM sleep behavior disorder. Mov Disord (2011) 0.93

Sleepiness in Parkinson's disease. Parkinsonism Relat Disord (2009) 0.93

HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy. Am J Hum Genet (2015) 0.91

Ropinirole in a child with attention-deficit hyperactivity disorder and restless legs syndrome. Pediatr Neurol (2005) 0.91

Sertraline and rapid eye movement sleep without atonia: an 8-week, open-label study of depressed patients. Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.89

The improvement of movement and speech during rapid eye movement sleep behaviour disorder in multiple system atrophy. Brain (2011) 0.88

Effects of venous compression of the legs on overnight rostral fluid shift and obstructive sleep apnea. Respir Physiol Neurobiol (2011) 0.88

Effectiveness of iron supplementation in a young child with attention-deficit/hyperactivity disorder. Pediatrics (2005) 0.88

Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: a long-term chart review. Sleep Med (2012) 0.87

Pitolisant, an inverse agonist of the histamine H3 receptor: an alternative stimulant for narcolepsy-cataplexy in teenagers with refractory sleepiness. Clin Neuropharmacol (2012) 0.86

Kleine-Levin syndrome and bipolar disorder: a differential diagnosis of recurrent and resistant depression. Bipolar Disord (2013) 0.85

Genetics of restless legs syndrome (RLS): State-of-the-art and future directions. Mov Disord (2007) 0.85

Responses of the diaphragm to transcranial magnetic stimulation during wake and sleep in humans. Respir Physiol Neurobiol (2006) 0.85

A brainstem inflammatory lesion causing REM sleep behavior disorder and sleepwalking (parasomnia overlap disorder). Sleep Med (2009) 0.85

Impact of obesity in children with narcolepsy. CNS Neurosci Ther (2013) 0.85

Obstructive sleep apnea and venous thromboembolism. JAMA (2002) 0.84

Hallucinations in narcolepsy with and without cataplexy: contrasts with Parkinson's disease. Sleep Med (2011) 0.84

Subjective symptoms in idiopathic hypersomnia: beyond excessive sleepiness. J Sleep Res (2010) 0.84

Narcolepsy and pregnancy: a retrospective European evaluation of 249 pregnancies. J Sleep Res (2013) 0.84

Autonomic symptoms in idiopathic REM behavior disorder: a multicentre case-control study. J Neurol (2014) 0.83

Abnormal respiratory-related evoked potentials in untreated awake patients with severe obstructive sleep apnoea syndrome. Clin Physiol Funct Imaging (2008) 0.83

Family-based association study of the restless legs syndrome loci 2 and 3 in a European population. Mov Disord (2007) 0.83

Sensations in restless legs syndrome. Sleep Med (2012) 0.83

Sleep and rhythm consequences of a genetically induced loss of serotonin. Sleep (2010) 0.83

Narcolepsy with long sleep time: a specific entity? Sleep (2009) 0.82

Evidence for the re-enactment of a recently learned behavior during sleepwalking. PLoS One (2011) 0.82

Diagnostic indicators of restless legs syndrome in primary care consultations: the DESYR study. Mov Disord (2007) 0.82

Major depression after withdrawing dopamine agonists in two patients with restless legs syndrome and impulse control disorders. Sleep Med (2013) 0.81

REM sleep behavior disorder in patients with guadeloupean parkinsonism, a tauopathy. Sleep (2007) 0.81

Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy. Sleep Med (2011) 0.81

Quality of life in children with narcolepsy. CNS Neurosci Ther (2014) 0.81

Functional imaging of cataplexy during status cataplecticus. Sleep (2007) 0.80

Attenuation of obstructive sleep apnea and overnight rostral fluid shift by physical activity. Am J Respir Crit Care Med (2015) 0.80

Sodium oxybate for excessive daytime sleepiness in narcolepsy-cataplexy. Sleep (2004) 0.79

Not all that goes "bump in the night" is RLS: leg motor restlessness in PD. Neurology (2011) 0.79

Rett syndrome: an overlooked diagnosis in women with stereotypic hand movements, psychomotor retardation, Parkinsonism, and dystonia? Mov Disord (2007) 0.79

Dopamine dysregulation syndrome in a patient with restless legs syndrome. Sleep Med (2009) 0.78

Periodic leg movements and REM sleep without atonia in Parkinson's disease with camptocormia. Mov Disord (2009) 0.78

Restless legs syndrome, rapid eye movement sleep behavior disorder, and hypersomnia in patients with two parkin mutations. Mov Disord (2009) 0.78

Video-clinical corners. Snoring, penile erection and loss of reflexive consciousness during REM sleep behavior disorder. Sleep Med (2010) 0.78

Walking dreams in congenital and acquired paraplegia. Conscious Cogn (2011) 0.78

Disappearance of "phantom limb" and amputated arm usage during dreaming in REM sleep behaviour disorder. BMJ Case Rep (2009) 0.77

Case scenario: anesthetic implications of restless legs syndrome. Anesthesiology (2010) 0.77

Two early descriptions of restless legs syndrome and periodic leg movements by Boissier de Sauvages (1763) and Gilles de la Tourette (1898). Sleep Med (2008) 0.76

The high frequency of restless legs syndrome in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2011) 0.76

Dreaming without REM sleep. Conscious Cogn (2012) 0.75

Increasing histamine neurotransmission in Gilles de la Tourette syndrome. J Neurol (2011) 0.75

Painful restless legs syndrome: a severe, burning form of the disease. Clin J Pain (2015) 0.75

[Sleepiness complaint: when is it necessary to monitor sleep?]. Rev Prat (2016) 0.75

Is sleep-related verbal memory consolidation impaired in sleepwalkers? J Sleep Res (2014) 0.75

Dopaminergic drug response and the genotype (Taq IA polymorphism) of the dopamine D2 receptor. Int J Neuropsychopharmacol (2000) 0.75